Results 71 to 80 of about 3,875 (181)
ABSTRACT The epidemiology of myelodysplastic syndromes/neoplasms (MDS) is challenging to define due to inconsistent reporting, complex diagnostic procedures, and evolving diagnostic criteria. Using the National MDS Natural History Study—a prospective cohort with centrally adjudicated histopathology and genetic variant review—we characterized the ...
Nancy Gillis +25 more
wiley +1 more source
Mutations of the SET binding protein 1 gene (SETBP1) on 18q12.3 have recently been reported to cause Schinzel-Giedion syndrome (SGS). As rare 18q interstitial deletions affecting multiple genes including SETBP1 correlate with a milder phenotype ...
Huber, Andreas R. +9 more
core +1 more source
Abstract Lenalidomide (Len) is the standard of care for red blood cell transfusion‐dependent (TD) patients with myelodysplastic syndromes (MDS) and del(5q). A Phase III clinical trial (SintraRev) demonstrated better efficacy of early treatment with Len in anemic del(5q) MDS patients prior to TD, but clonal evolution with this approach remained ...
Sofía Toribio Castelló +20 more
wiley +1 more source
Abstract Myelodysplastic syndromes (MDS) are clinically and biologically diverse disorders, emphasizing the need for personalized treatment approaches. The International Working Group for Prognostication of MDS (IWG_PM) recently introduced a molecular classification, referred to as the MDS taxonomy, that categorizes patients into 16 subgroups based on ...
Giulia Maggioni +90 more
wiley +1 more source
Begg’s funnel plot of the prognostic significance of SETBP1 mutation in CNL patients.
Begg’s funnel plot of the prognostic significance of SETBP1 mutation in CNL patients.
Xiao-Hui Dong (3716569) +7 more
core +1 more source
Tissue-specific TF activity of SETBP1 and TFs it targets.
Heatmap representing TF activity scores of SETBP1 (purple) and its known TF targets (black, y-axis) across GTEx tissues (x-axis). Affected tissues in SETBP1-associated diseases are indicated by a purple star (x-axis).
Amanda D. Clark (5257955) +4 more
core +1 more source
Epigenome-wide methylation differences in a group of lean and obese women – A HUNT Study
Knowledge of epigenetically regulated biomarkers linked to obesity development is still scarce. Improving molecular understanding of the involved factors and pathways would improve obesity phenotype characterization and reveal potentially relevant ...
Kirsti Kvaløy +2 more
doaj +1 more source
Mutations of the SET binding protein 1 (SETBP1) gene have been identified in patients with myeloid neoplasms, but the clinical relevance of this mutation and its association with other gene mutations in myelodysplastic syndrome (MDS) and the stability ...
Hou, Hsin-An;Kuo, Yuan-Yeh;Tang, Jih-Luh;Chou, Wen-Chien;Yao, Ming;Lai, Yan-Jun;Lin, Chien-Chin;Chen, Chien-Yuan;Liu, Chieh-Yu;Tseng, Mei-Hsuan;Huang, Chi-Fei;Chiang, Ying-Chieh;Lee, Fen-Yu;Liu, Ming-Chih;Liu, Chia-Wen;Huang, Shang-Yi;Ko, Bor-Sheng;Wu, Shang-Ju;Tsay, Woei;Chen, Yao-Chang;Tien, Hwei-Fang +1 more
core +1 more source
Begg’s funnel plot of the prognostic significance of SETBP1 mutation in CMML patients.
Begg’s funnel plot of the prognostic significance of SETBP1 mutation in CMML patients.
Xiao-Hui Dong (3716569) +7 more
core +1 more source
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
: SETBP1 mutations are found in various clonal myeloid disorders. However, it is unclear whether they can initiate leukemia, as SETBP1 mutations typically appear as later events during oncogenesis.
Barone, Cristiana +47 more
core +1 more source

